Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery
Abstract Although the drug-eluting stent (DES) has become the standard for percutaneous coronary intervention (PCI)-based revascularization, concerns remain regarding the use of DES, mainly due to its permanent rigid constraint to vessels. A drug-eluting bioresorbable stent (BRS) was thus developed...
Guardado en:
Autores principales: | Jinzhou Zhu, Xiyuan Zhang, Jialin Niu, Yongjuan Shi, Zhengbin Zhu, Daopeng Dai, Chenxin Chen, Jia Pei, Guangyin Yuan, Ruiyan Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d64f5a5a558f4985b72746de66273925 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Cheng-Hung Lee, et al.
Publicado: (2017) -
Everolimus-eluting coronary stents
por: Alejandro Saez, et al.
Publicado: (2010) -
Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results
por: Schurtz G, et al.
Publicado: (2014) -
Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
por: Xinlin Zhang, et al.
Publicado: (2014) -
Pathological findings after third- and second-generation everolimus-eluting stent implantations in coronary arteries from autopsy cases and an atherosclerotic porcine model
por: Suguru Migita, et al.
Publicado: (2021)